NextGen Jane
Oakland, US · Founded 2014 · Delaware corporation · 1 known investors
NextGen Jane operates a longitudinal molecular study of women's menstruation, collecting samples through a patented at-home kit to generate genomic insights into reproductive and gynecological health. The company serves women seeking to understand menstrual cycles, fertility, and conditions like endometriosis through advanced diagnostics and personalized health insights.
Founders & leadership
SG
Stephen GireDirector
RT
Ridhi TariyalExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$7MraisedOct 2023 · 7 investors · Other Health CareRule 506(b)
▶$7MraisedOct 2023 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen GireExecutive Officer, Director
- Deborah KilpatrickDirector
- Ridhi TariyalExecutive Officer, Director
- Adam SharkawyDirector
- Offering amount
- $7.8M
- Amount sold
- $7M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJun 2022 · 2 investors · Other Health CareRule 506(b)
▶$1.5MraisedJun 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN GIREExecutive Officer, Director
- RIDHI TARIYALExecutive Officer, Director
- DEBORAH KILPATRICKDirector
- ADAM SHARKAWYDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.7MraisedApr 2019 · 14 investors · Other Health CareRule 506(b)
▶$8.7MraisedApr 2019 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam SharkawyDirector
- Stephen GireExecutive Officer, Director
- Ridhi TariyalExecutive Officer, Director
- Deborah KilpatrickDirector
- Offering amount
- $8.7M
- Amount sold
- $8.7M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedMar 2016 · 7 investors · Other Health CareRule 506(b)
▶$2.2MraisedMar 2016 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen GireDirector
- Ridhi TariyalExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.2M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.